|
NDUFS5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.61739527221516E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.38539957283967E-10 |
| Normal-vs-Stage2 |
1.99810000000022E-05 |
| Normal-vs-Stage3 |
2.05129999653053E-08 |
| Normal-vs-Stage4 |
1.75810000002663E-06 |
| Stage1-vs-Stage2 |
5.599600E-01 |
| Stage1-vs-Stage3 |
9.660400E-01 |
| Stage1-vs-Stage4 |
6.175400E-01 |
| Stage2-vs-Stage3 |
5.417400E-01 |
| Stage2-vs-Stage4 |
3.824800E-01 |
| Stage3-vs-Stage4 |
6.652400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.04710018433707E-10 |
| Normal-vs-AfricanAmerican |
3.601100E-04 |
| Normal-vs-Asian |
1.81820999999305E-05 |
| Caucasian-vs-AfricanAmerican |
1.465960E-01 |
| Caucasian-vs-Asian |
6.526400E-01 |
| AfricanAmerican-vs-Asian |
2.012000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.48210032924601E-10 |
| Normal-vs-Female |
1.93929983183239E-10 |
| Male-vs-Female |
2.883400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.53750370610351E-11 |
| Normal-vs-Age(41-60Yrs) |
4.65310012742748E-10 |
| Normal-vs-Age(61-80Yrs) |
1.74531000000089E-05 |
| Normal-vs-Age(81-100Yrs) |
1.156380E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.775600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.708500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.373800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.654360E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.553000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.493800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.345800E-01 |
| Classical-VS-Follicular |
2.981800E-01 |
| Classical-VS-Other |
5.770000E-01 |
| Classical-VS-Normal |
2.17780016242841E-10 |
| Tall-VS-Follicular |
3.487000E-01 |
| Tall-VS-Other |
5.443000E-01 |
| Tall-VS-Normal |
3.52559999999835E-05 |
| Follicular-VS-Other |
7.744200E-01 |
| Follicular-VS-Normal |
5.32149999621367E-08 |
| Other-VS-Normal |
6.582000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.20370047262952E-10 |
| Normal-vs-N1 |
3.26510000037139E-07 |
| N0-vs-N1 |
6.993200E-01 |
|
|
